Biodefense R&D: First Anthrax Vaccine Could Enter Phase II In 2004

An HHS contract is supporting the development of VaxGen's recombinant anthrax vaccine. Acambis/Baxter's second-generation smallpox vaccine ACAM-2000 is in Phase II.